GSK Statement: GSK Voluntary Recall of VENTOLIN DISKUS Lot 786G in Canada

GSK is voluntarily recalling one lot (Lot 786G of VENTOLIN DISKUS 200mcg in Canada). We are taking this action after becoming aware of a manufacturing issue that may result in a small number of VENTOLIN DISKUS devices not delivering the full number of doses in the device. No adverse events have been reported as a result of this manufacturing issue, however, patient safety remains our absolute priority and we are taking this issue very seriously.

We ask patients with VENTOLIN DISKUS to check the lot details on their device. The lot number is contained on the bottom of the VENTOLIN DISKUS cardboard package (4 characters after the word “lot”) or in the centre of the device (similarly 4 characters after the word “lot”). VENTOLIN DISKUS devices carrying the recalled lot number 786G should be returned to your local pharmacy for replacement.

VENTOLIN metered dose inhalers, commonly referred to as “puffers” (tradename “VENTOLIN HFA”) are not affected by this issue and patients can continue to use as prescribed by their healthcare professional.

We have carried out a thorough investigation and the root cause of the issue has been corrected. We are committed to supplying high-quality products to Canadian patients and sincerely regret any inconvenience patients and healthcare professionals may experience related to this recall.

GSK enquiries: 

Corporate Communications

+1 905-819-3363




+1 450-680-4812